GLYC
Price
$0.26
Change
-$0.00 (-0.00%)
Updated
Apr 28, 04:53 PM (EDT)
Capitalization
16.84M
3 days until earnings call
LYRA
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
6.92M
15 days until earnings call
Ad is loading...

GLYC vs LYRA

Header iconGLYC vs LYRA Comparison
Open Charts GLYC vs LYRABanner chart's image
GlycoMimetics
Price$0.26
Change-$0.00 (-0.00%)
Volume$127
Capitalization16.84M
Lyra Therapeutics
Price$0.10
Change-$0.00 (-0.00%)
Volume$2.89K
Capitalization6.92M
GLYC vs LYRA Comparison Chart
Loading...
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLYC vs. LYRA commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLYC is a StrongBuy and LYRA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (GLYC: $0.26 vs. LYRA: $0.10)
Brand notoriety: GLYC and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLYC: 124% vs. LYRA: 101%
Market capitalization -- GLYC: $16.84M vs. LYRA: $6.92M
GLYC [@Biotechnology] is valued at $16.84M. LYRA’s [@Biotechnology] market capitalization is $6.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLYC’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • GLYC’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, GLYC is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLYC’s TA Score shows that 5 TA indicator(s) are bullish while LYRA’s TA Score has 6 bullish TA indicator(s).

  • GLYC’s TA Score: 5 bullish, 4 bearish.
  • LYRA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than GLYC.

Price Growth

GLYC (@Biotechnology) experienced а +17.04% price change this week, while LYRA (@Biotechnology) price change was +21.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.19%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

GLYC is expected to report earnings on Jul 30, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLYC($16.8M) has a higher market cap than LYRA($6.92M). GLYC YTD gains are higher at: 4.819 vs. LYRA (-49.128). GLYC has higher annual earnings (EBITDA): -32.47M vs. LYRA (-60.26M). LYRA has more cash in the bank: 40.6M vs. GLYC (10.7M). GLYC has less debt than LYRA: GLYC (66.8K) vs LYRA (34.4M). LYRA has higher revenues than GLYC: LYRA (1.53M) vs GLYC (0).
GLYCLYRAGLYC / LYRA
Capitalization16.8M6.92M243%
EBITDA-32.47M-60.26M54%
Gain YTD4.819-49.128-10%
P/E RatioN/AN/A-
Revenue01.53M-
Total Cash10.7M40.6M26%
Total Debt66.8K34.4M0%
FUNDAMENTALS RATINGS
GLYC: Fundamental Ratings
GLYC
OUTLOOK RATING
1..100
48
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLYCLYRA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 22 days ago
86%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDC2.360.37
+18.59%
GD Culture Group Limited
GBDC14.44-0.02
-0.14%
Golub Capital BDC
LECO185.76-0.58
-0.31%
Lincoln Electric Holdings
FENC5.63-0.06
-1.05%
Fennec Pharmaceuticals
ARKO4.18-0.05
-1.18%
ARKO Corp